Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Erson-Omay EZ"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-6 z 6
    Tytuł:
    Correction: Genomic profiling of sporadic multiple meningiomas.
    Autorzy:
    Erson-Omay EZ; Department of Neurosurgery, Yale School of Medicine, 15 York St, LLCI 810, New Haven, CT, 06520-8082, USA. zeynep.erson@yale.edu.; The Chênevert Family Brain Tumor Center, Smilow Cancer Hospital, New Haven, CT, USA. zeynep.erson@yale.edu.; The Susan Beris, MD Neurosurgical Oncology Program at Yale New Haven Hospital, New Haven, CT, USA. zeynep.erson@yale.edu.
    Vetsa S; Department of Neurosurgery, Yale School of Medicine, 15 York St, LLCI 810, New Haven, CT, 06520-8082, USA.; The Chênevert Family Brain Tumor Center, Smilow Cancer Hospital, New Haven, CT, USA.; The Susan Beris, MD Neurosurgical Oncology Program at Yale New Haven Hospital, New Haven, CT, USA.
    Vasandani S; Department of Neurosurgery, Yale School of Medicine, 15 York St, LLCI 810, New Haven, CT, 06520-8082, USA.; The Chênevert Family Brain Tumor Center, Smilow Cancer Hospital, New Haven, CT, USA.; The Susan Beris, MD Neurosurgical Oncology Program at Yale New Haven Hospital, New Haven, CT, USA.
    Barak T; Department of Neurosurgery, Yale School of Medicine, 15 York St, LLCI 810, New Haven, CT, 06520-8082, USA.; The Chênevert Family Brain Tumor Center, Smilow Cancer Hospital, New Haven, CT, USA.
    Nadar A; Department of Neurosurgery, Yale School of Medicine, 15 York St, LLCI 810, New Haven, CT, 06520-8082, USA.; The Chênevert Family Brain Tumor Center, Smilow Cancer Hospital, New Haven, CT, USA.; The Susan Beris, MD Neurosurgical Oncology Program at Yale New Haven Hospital, New Haven, CT, USA.
    Marianayagam NJ; Department of Neurosurgery, Yale School of Medicine, 15 York St, LLCI 810, New Haven, CT, 06520-8082, USA.; The Chênevert Family Brain Tumor Center, Smilow Cancer Hospital, New Haven, CT, USA.; The Susan Beris, MD Neurosurgical Oncology Program at Yale New Haven Hospital, New Haven, CT, USA.
    Yalcin K; Department of Neurosurgery, Yale School of Medicine, 15 York St, LLCI 810, New Haven, CT, 06520-8082, USA.; The Chênevert Family Brain Tumor Center, Smilow Cancer Hospital, New Haven, CT, USA.
    Miyagishima D; Department of Neurosurgery, Yale School of Medicine, 15 York St, LLCI 810, New Haven, CT, 06520-8082, USA.; The Chênevert Family Brain Tumor Center, Smilow Cancer Hospital, New Haven, CT, USA.
    Aguilera SM; Department of Neurosurgery, Yale School of Medicine, 15 York St, LLCI 810, New Haven, CT, 06520-8082, USA.; The Chênevert Family Brain Tumor Center, Smilow Cancer Hospital, New Haven, CT, USA.
    Robert S; Department of Neurosurgery, Yale School of Medicine, 15 York St, LLCI 810, New Haven, CT, 06520-8082, USA.; The Chênevert Family Brain Tumor Center, Smilow Cancer Hospital, New Haven, CT, USA.; The Susan Beris, MD Neurosurgical Oncology Program at Yale New Haven Hospital, New Haven, CT, USA.
    Mishra-Gorur K; Department of Neurosurgery, Yale School of Medicine, 15 York St, LLCI 810, New Haven, CT, 06520-8082, USA.; The Chênevert Family Brain Tumor Center, Smilow Cancer Hospital, New Haven, CT, USA.
    Fulbright RK; Department of Radiology and Biomedical Imaging, Neuroradiology Section, Yale School of Medicine, New Haven, CT, USA.
    McGuone D; Department of Pathology, Yale School of Medicine, New Haven, CT, USA.
    Günel M; Department of Neurosurgery, Yale School of Medicine, 15 York St, LLCI 810, New Haven, CT, 06520-8082, USA.; The Chênevert Family Brain Tumor Center, Smilow Cancer Hospital, New Haven, CT, USA.; The Susan Beris, MD Neurosurgical Oncology Program at Yale New Haven Hospital, New Haven, CT, USA.; Department of Genetics, Yale School of Medicine, New Haven, CT, USA.
    Moliterno J; Department of Neurosurgery, Yale School of Medicine, 15 York St, LLCI 810, New Haven, CT, 06520-8082, USA. .; The Chênevert Family Brain Tumor Center, Smilow Cancer Hospital, New Haven, CT, USA. .; The Susan Beris, MD Neurosurgical Oncology Program at Yale New Haven Hospital, New Haven, CT, USA. .
    Pokaż więcej
    Źródło:
    BMC medical genomics [BMC Med Genomics] 2022 Jun 13; Vol. 15 (1), pp. 131. Date of Electronic Publication: 2022 Jun 13.
    Typ publikacji:
    Published Erratum
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Genomic profiling of sporadic multiple meningiomas.
    Autorzy:
    Erson-Omay EZ; Department of Neurosurgery, Yale School of Medicine, 15 York St, LLCI 810, New Haven, CT, 06520-8082, USA. zeynep.erson@yale.edu.; The Chênevert Family Brain Tumor Center, Smilow Cancer Hospital, New Haven, CT, USA. zeynep.erson@yale.edu.; The Susan Beris, MD Neurosurgical Oncology Program at Yale New Haven Hospital, New Haven, CT, USA. zeynep.erson@yale.edu.
    Vetsa S; Department of Neurosurgery, Yale School of Medicine, 15 York St, LLCI 810, New Haven, CT, 06520-8082, USA.; The Chênevert Family Brain Tumor Center, Smilow Cancer Hospital, New Haven, CT, USA.; The Susan Beris, MD Neurosurgical Oncology Program at Yale New Haven Hospital, New Haven, CT, USA.
    Vasandani S; Department of Neurosurgery, Yale School of Medicine, 15 York St, LLCI 810, New Haven, CT, 06520-8082, USA.; The Chênevert Family Brain Tumor Center, Smilow Cancer Hospital, New Haven, CT, USA.; The Susan Beris, MD Neurosurgical Oncology Program at Yale New Haven Hospital, New Haven, CT, USA.
    Barak T; Department of Neurosurgery, Yale School of Medicine, 15 York St, LLCI 810, New Haven, CT, 06520-8082, USA.; The Chênevert Family Brain Tumor Center, Smilow Cancer Hospital, New Haven, CT, USA.
    Nadar A; Department of Neurosurgery, Yale School of Medicine, 15 York St, LLCI 810, New Haven, CT, 06520-8082, USA.; The Chênevert Family Brain Tumor Center, Smilow Cancer Hospital, New Haven, CT, USA.; The Susan Beris, MD Neurosurgical Oncology Program at Yale New Haven Hospital, New Haven, CT, USA.
    Marianayagam NJ; Department of Neurosurgery, Yale School of Medicine, 15 York St, LLCI 810, New Haven, CT, 06520-8082, USA.; The Chênevert Family Brain Tumor Center, Smilow Cancer Hospital, New Haven, CT, USA.; The Susan Beris, MD Neurosurgical Oncology Program at Yale New Haven Hospital, New Haven, CT, USA.
    Yalcin K; Department of Neurosurgery, Yale School of Medicine, 15 York St, LLCI 810, New Haven, CT, 06520-8082, USA.; The Chênevert Family Brain Tumor Center, Smilow Cancer Hospital, New Haven, CT, USA.
    Miyagishima D; Department of Neurosurgery, Yale School of Medicine, 15 York St, LLCI 810, New Haven, CT, 06520-8082, USA.; The Chênevert Family Brain Tumor Center, Smilow Cancer Hospital, New Haven, CT, USA.
    Aguilera SM; Department of Neurosurgery, Yale School of Medicine, 15 York St, LLCI 810, New Haven, CT, 06520-8082, USA.; The Chênevert Family Brain Tumor Center, Smilow Cancer Hospital, New Haven, CT, USA.
    Robert S; Department of Neurosurgery, Yale School of Medicine, 15 York St, LLCI 810, New Haven, CT, 06520-8082, USA.; The Chênevert Family Brain Tumor Center, Smilow Cancer Hospital, New Haven, CT, USA.; The Susan Beris, MD Neurosurgical Oncology Program at Yale New Haven Hospital, New Haven, CT, USA.
    Mishra-Gorur K; Department of Neurosurgery, Yale School of Medicine, 15 York St, LLCI 810, New Haven, CT, 06520-8082, USA.; The Chênevert Family Brain Tumor Center, Smilow Cancer Hospital, New Haven, CT, USA.
    Fulbright RK; Department of Radiology and Biomedical Imaging, Neuroradiology Section, Yale School of Medicine, New Haven, CT, USA.
    McGuone D; Department of Pathology, Yale School of Medicine, New Haven, CT, USA.
    Günel M; Department of Neurosurgery, Yale School of Medicine, 15 York St, LLCI 810, New Haven, CT, 06520-8082, USA.; The Chênevert Family Brain Tumor Center, Smilow Cancer Hospital, New Haven, CT, USA.; The Susan Beris, MD Neurosurgical Oncology Program at Yale New Haven Hospital, New Haven, CT, USA.; Department of Genetics, Yale School of Medicine, New Haven, CT, USA.
    Moliterno J; Department of Neurosurgery, Yale School of Medicine, 15 York St, LLCI 810, New Haven, CT, 06520-8082, USA. .; The Chênevert Family Brain Tumor Center, Smilow Cancer Hospital, New Haven, CT, USA. .; The Susan Beris, MD Neurosurgical Oncology Program at Yale New Haven Hospital, New Haven, CT, USA. .
    Pokaż więcej
    Źródło:
    BMC medical genomics [BMC Med Genomics] 2022 May 14; Vol. 15 (1), pp. 112. Date of Electronic Publication: 2022 May 14.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Meningeal Neoplasms*/genetics
    Meningeal Neoplasms*/pathology
    Meningioma*/genetics
    Meningioma*/pathology
    Cohort Studies ; Genomics ; Humans
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Dual activating FGFR1 mutations in pediatric pilomyxoid astrocytoma.
    Autorzy:
    Fomchenko EI; Department of Neurosurgery, Yale School of Medicine, New Haven, CT, USA.
    Reeves BC; Department of Neurosurgery, Yale School of Medicine, New Haven, CT, USA.
    Sullivan W; Department of Neurosurgery, Yale School of Medicine, New Haven, CT, USA.
    Marks AM; Department of Pediatrics, Hematology/Oncology, Yale School of Medicine, New Haven, CT, USA.
    Huttner A; Department of Pathology, Yale School of Medicine, New Haven, CT, USA.
    Kahle KT; Department of Neurosurgery, Yale School of Medicine, New Haven, CT, USA.; Centers for Mendelian Genomics and Yale Program on Neurogenetics, Yale School of Medicine, New Haven, CT, USA.; Department Cellular & Molecular Physiology, Yale School of Medicine, New Haven, CT, USA.
    Erson-Omay EZ; Department of Neurosurgery, Yale School of Medicine, New Haven, CT, USA.
    Pokaż więcej
    Źródło:
    Molecular genetics & genomic medicine [Mol Genet Genomic Med] 2021 Feb; Vol. 9 (2), pp. e1597. Date of Electronic Publication: 2021 Jan 14.
    Typ publikacji:
    Case Reports; Journal Article; Research Support, N.I.H., Extramural
    MeSH Terms:
    Astrocytoma/*genetics
    Brain Neoplasms/*genetics
    Receptor, Fibroblast Growth Factor, Type 1/*genetics
    Astrocytoma/pathology ; Astrocytoma/surgery ; Brain Neoplasms/pathology ; Brain Neoplasms/surgery ; Humans ; Infant ; Male ; Mutation, Missense ; Receptor, Fibroblast Growth Factor, Type 1/metabolism
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Longitudinal analysis of treatment-induced genomic alterations in gliomas.
    Autorzy:
    Erson-Omay EZ; Yale Program in Brain Tumor Research, Yale School of Medicine, New Haven, CT, USA.; Department of Neurosurgery, Yale School of Medicine, New Haven, CT, USA.
    Henegariu O; Yale Program in Brain Tumor Research, Yale School of Medicine, New Haven, CT, USA.; Department of Neurosurgery, Yale School of Medicine, New Haven, CT, USA.; Department of Genetics, Yale School of Medicine, New Haven, CT, USA.; Department of Neurobiology, Yale School of Medicine, New Haven, CT, USA.; Yale Program on Neurogenetics, Yale School of Medicine, New Haven, CT, USA.
    Omay SB; Yale Program in Brain Tumor Research, Yale School of Medicine, New Haven, CT, USA.; Department of Neurosurgery, Yale School of Medicine, New Haven, CT, USA.
    Harmancı AS; Yale Program in Brain Tumor Research, Yale School of Medicine, New Haven, CT, USA.; Department of Neurosurgery, Yale School of Medicine, New Haven, CT, USA.
    Youngblood MW; Yale Program in Brain Tumor Research, Yale School of Medicine, New Haven, CT, USA.; Department of Neurosurgery, Yale School of Medicine, New Haven, CT, USA.; Department of Genetics, Yale School of Medicine, New Haven, CT, USA.
    Mishra-Gorur K; Yale Program in Brain Tumor Research, Yale School of Medicine, New Haven, CT, USA.; Department of Neurosurgery, Yale School of Medicine, New Haven, CT, USA.; Department of Genetics, Yale School of Medicine, New Haven, CT, USA.; Department of Neurobiology, Yale School of Medicine, New Haven, CT, USA.; Yale Program on Neurogenetics, Yale School of Medicine, New Haven, CT, USA.
    Li J; Department of Pathology, Yale School of Medicine, New Haven, CT, USA.
    Özduman K; Department of Neurosurgery, Acıbadem University School of Medicine, Istanbul, Turkey.
    Carrión-Grant G; Yale Program in Brain Tumor Research, Yale School of Medicine, New Haven, CT, USA.; Department of Neurosurgery, Yale School of Medicine, New Haven, CT, USA.
    Clark VE; Yale Program in Brain Tumor Research, Yale School of Medicine, New Haven, CT, USA.; Department of Neurosurgery, Yale School of Medicine, New Haven, CT, USA.; Department of Genetics, Yale School of Medicine, New Haven, CT, USA.
    Çağlar C; Yale Program in Brain Tumor Research, Yale School of Medicine, New Haven, CT, USA.; Department of Neurosurgery, Yale School of Medicine, New Haven, CT, USA.
    Bakırcıoğlu M; Yale Program in Brain Tumor Research, Yale School of Medicine, New Haven, CT, USA.; Department of Neurosurgery, Yale School of Medicine, New Haven, CT, USA.
    Pamir MN; Department of Neurosurgery, Acıbadem University School of Medicine, Istanbul, Turkey.
    Tabar V; Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
    Vortmeyer AO; Department of Pathology, Yale School of Medicine, New Haven, CT, USA.
    Bilguvar K; Yale Program in Brain Tumor Research, Yale School of Medicine, New Haven, CT, USA.; Department of Genetics, Yale School of Medicine, New Haven, CT, USA.; Yale Program on Neurogenetics, Yale School of Medicine, New Haven, CT, USA.; Yale Center for Genome Analysis, Yale School of Medicine, Orange, CT, USA.
    Yasuno K; Yale Program in Brain Tumor Research, Yale School of Medicine, New Haven, CT, USA.; Department of Neurosurgery, Yale School of Medicine, New Haven, CT, USA.
    DeAngelis LM; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
    Baehring JM; Department of Neurosurgery, Yale School of Medicine, New Haven, CT, USA.; Department of Neurology, Yale School of Medicine, New Haven, CT, USA.; Yale Brain Tumor Center, Yale School of Medicine, New Haven, CT, USA.
    Moliterno J; Yale Program in Brain Tumor Research, Yale School of Medicine, New Haven, CT, USA.; Department of Neurosurgery, Yale School of Medicine, New Haven, CT, USA.; Yale Brain Tumor Center, Yale School of Medicine, New Haven, CT, USA.
    Günel M; Yale Program in Brain Tumor Research, Yale School of Medicine, New Haven, CT, USA. .; Department of Neurosurgery, Yale School of Medicine, New Haven, CT, USA. .; Department of Genetics, Yale School of Medicine, New Haven, CT, USA. .; Department of Neurobiology, Yale School of Medicine, New Haven, CT, USA. .; Yale Program on Neurogenetics, Yale School of Medicine, New Haven, CT, USA. .; Yale Brain Tumor Center, Yale School of Medicine, New Haven, CT, USA. .; Yale Comprehensive Cancer Center, Yale School of Medicine, New Haven, CT, USA. .; Yale Neurosurgery, PO Box 208082, New Haven, CT, 06520-8082, USA. .
    Pokaż więcej
    Źródło:
    Genome medicine [Genome Med] 2017 Feb 02; Vol. 9 (1), pp. 12. Date of Electronic Publication: 2017 Feb 02.
    Typ publikacji:
    Case Reports; Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Chromosome Aberrations*
    Genomics*
    Neoplasm Recurrence, Local*
    Precision Medicine*
    Glioblastoma/*therapy
    Antineoplastic Agents/therapeutic use ; Combined Modality Therapy ; DNA Mismatch Repair ; DNA Mutational Analysis ; DNA, Neoplasm ; Disease Progression ; Exome ; Female ; General Surgery ; Genome, Human ; Glioblastoma/genetics ; Glioblastoma/pathology ; Humans ; Immunotherapy ; Longitudinal Studies ; Middle Aged ; Mutation ; Radiotherapy ; Treatment Outcome
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    IDH-mutant glioma specific association of rs55705857 located at 8q24.21 involves MYC deregulation.
    Autorzy:
    Oktay Y; Brain Tumor Research Group, Acibadem University, Istanbul, Turkey.; Department of Molecular Biology and Genetics, Faculty of Arts and Sciences, Acibadem University, Istanbul, Turkey.; Department of Medical Biology, School of Medicine, Acibadem University, Istanbul, Turkey.; Izmir International Biomedicine and Genome Institute (iBG-izmir), Dokuz Eylul University, Izmir, Turkey.
    Ülgen E; Brain Tumor Research Group, Acibadem University, Istanbul, Turkey.
    Can Ö; Brain Tumor Research Group, Acibadem University, Istanbul, Turkey.; Faculty of Engineering, Department of Medical Engineering, Acibadem University, Istanbul, Turkey.
    Akyerli CB; Brain Tumor Research Group, Acibadem University, Istanbul, Turkey.; Department of Molecular Biology and Genetics, Faculty of Arts and Sciences, Acibadem University, Istanbul, Turkey.; Department of Medical Biology, School of Medicine, Acibadem University, Istanbul, Turkey.
    Yüksel Ş; Brain Tumor Research Group, Acibadem University, Istanbul, Turkey.; Department of Medical Biology, School of Medicine, Acibadem University, Istanbul, Turkey.
    Erdemgil Y; Brain Tumor Research Group, Acibadem University, Istanbul, Turkey.
    Durası IM; Department of Biological Sciences and Bioengineering, Faculty of Engineering and Natural Sciences, Sabanci University, Istanbul, Turkey.
    Henegariu OI; Department of Neurosurgery, School of Medicine Yale University, New Haven, CT 06520, USA.
    Nanni EP; Functional Genomics Center Zurich, UZH/ETH, Zurich, Switzerland.
    Selevsek N; Functional Genomics Center Zurich, UZH/ETH, Zurich, Switzerland.
    Grossmann J; Functional Genomics Center Zurich, UZH/ETH, Zurich, Switzerland.
    Erson-Omay EZ; Department of Neurosurgery, School of Medicine Yale University, New Haven, CT 06520, USA.
    Bai H; Department of Neurosurgery, School of Medicine Yale University, New Haven, CT 06520, USA.
    Gupta M; Cancer Institute, University College London, 72 Huntley Street, WC1E 6DD, London, UK.
    Lee W; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
    Turcan Ş; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
    Özpınar A; Brain Tumor Research Group, Acibadem University, Istanbul, Turkey.; Department of Medical Biochemistry, School of Medicine, Acibadem University, Istanbul, Turkey.
    Huse JT; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
    Sav MA; Brain Tumor Research Group, Acibadem University, Istanbul, Turkey.; Department of Pathology, School of Medicine, Acibadem University, Istanbul, Turkey.
    Flanagan A; Cancer Institute, University College London, 72 Huntley Street, WC1E 6DD, London, UK.
    Günel M; Department of Neurosurgery, School of Medicine Yale University, New Haven, CT 06520, USA.
    Sezerman OU; Brain Tumor Research Group, Acibadem University, Istanbul, Turkey.; Department of Medical Statistics and Bioinformatics, School of Medicine, Acibadem University, Istanbul, Turkey.
    Yakıcıer MC; Brain Tumor Research Group, Acibadem University, Istanbul, Turkey.; Department of Molecular Biology and Genetics, Faculty of Arts and Sciences, Acibadem University, Istanbul, Turkey.; Department of Medical Biology, School of Medicine, Acibadem University, Istanbul, Turkey.
    Pamir MN; Brain Tumor Research Group, Acibadem University, Istanbul, Turkey.; Department of Neurosurgery, School of Medicine, Acibadem University, Istanbul, Turkey.
    Özduman K; Brain Tumor Research Group, Acibadem University, Istanbul, Turkey.; Department of Neurosurgery, School of Medicine, Acibadem University, Istanbul, Turkey.
    Pokaż więcej
    Źródło:
    Scientific reports [Sci Rep] 2016 Jun 10; Vol. 6, pp. 27569. Date of Electronic Publication: 2016 Jun 10.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Genetic Association Studies*
    Biomarkers, Tumor/*genetics
    Glioma/*genetics
    Proto-Oncogene Proteins c-myc/*genetics
    Adult ; Aged ; Alleles ; Female ; Gene Expression Regulation, Neoplastic ; Genetic Predisposition to Disease ; Glioma/pathology ; Humans ; Isocitrate Dehydrogenase/genetics ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Mutation ; Neoplasm Grading ; Neoplasm Proteins/genetics ; Polymorphism, Single Nucleotide ; Proteomics ; Sequence Analysis, RNA
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO.
    Autorzy:
    Clark VE; Department of Neurosurgery, Yale Program in Brain Tumor Research, Yale School of Medicine, New Haven, CT 06510, USA.
    Erson-Omay EZ
    Serin A
    Yin J
    Cotney J
    Ozduman K
    Avşar T
    Li J
    Murray PB
    Henegariu O
    Yilmaz S
    Günel JM
    Carrión-Grant G
    Yilmaz B
    Grady C
    Tanrikulu B
    Bakircioğlu M
    Kaymakçalan H
    Caglayan AO
    Sencar L
    Ceyhun E
    Atik AF
    Bayri Y
    Bai H
    Kolb LE
    Hebert RM
    Omay SB
    Mishra-Gorur K
    Choi M
    Overton JD
    Holland EC
    Mane S
    State MW
    Bilgüvar K
    Baehring JM
    Gutin PH
    Piepmeier JM
    Vortmeyer A
    Brennan CW
    Pamir MN
    Kiliç T
    Lifton RP
    Noonan JP
    Yasuno K
    Günel M
    Pokaż więcej
    Źródło:
    Science (New York, N.Y.) [Science] 2013 Mar 01; Vol. 339 (6123), pp. 1077-80. Date of Electronic Publication: 2013 Jan 24.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Brain Neoplasms/*genetics
    Kruppel-Like Transcription Factors/*genetics
    Meningeal Neoplasms/*genetics
    Meningioma/*genetics
    Proto-Oncogene Proteins c-akt/*genetics
    Receptors, G-Protein-Coupled/*genetics
    Tumor Necrosis Factor Receptor-Associated Peptides and Proteins/*genetics
    Adult ; Aged ; Aged, 80 and over ; Brain Neoplasms/classification ; Brain Neoplasms/pathology ; Chromosomes, Human, Pair 22/genetics ; DNA Mutational Analysis ; Female ; Genes, Neurofibromatosis 2 ; Genomic Instability ; Genomics ; Humans ; Kruppel-Like Factor 4 ; Male ; Meningeal Neoplasms/classification ; Meningeal Neoplasms/pathology ; Meningioma/classification ; Meningioma/pathology ; Middle Aged ; Mutation ; Neoplasm Grading ; Smoothened Receptor
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
      Wyświetlanie 1-6 z 6

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies